Recasting natural product research

Nature Biotechnology

Volumn 30, Issue 5, 2012, Pages 385-387

  Sheridan, Cormac ^a  

^a NONE   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT;

BIOTECHNOLOGY; CHEMISTRY; COMMERCIAL PHENOMENA; DRUG DESIGN; FINANCIAL MANAGEMENT; HUMAN; INVESTMENT; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METABOLISM; METHODOLOGY; NOTE; UNITED STATES;

BIOLOGICAL AGENTS; BIOTECHNOLOGY; CAPITAL FINANCING; CHEMISTRY, PHARMACEUTICAL; COMMERCE; DRUG DESIGN; HUMANS; INVESTMENTS; PLANTS, MEDICINAL; UNITED STATES;

EID: 84865674915     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2208     Document Type: Note

References (6)

1. Davies, J. & Ryan, K.S. ACS Chem. Biol. 7, 252–259 (2012).
2. Zazopoulos, E. et al. Nat. Biotechnol. 21, 187–190 (2003).
3. McAlpine, J.B. et al. J. Nat. Prod. 68, 493–496 (2005).
4. Banskota, A.H. et al. J. Antibiot. (Tokyo) 59, 168–176 (2006).
5. Banskota, A.H. et al. J. Antibiot. (Tokyo) 59, 533–542 (2006).
6. Moss, S.J. et al. Med. Chem. Commun. doi:10.1039/C1MD00227A (2012).